Earnings call transcript: One Stop Systems beats Q4 2025 EPS forecast

One Stop Systems reported EPS $0.09 vs $0.03 consensus (200% surprise) but missed revenue at $11.99M vs $18.83M forecast (-36.33%); reported revenue was $12.0M (+70.2% YoY), gross margin a record 58.5%, net income $2.0M and adjusted EBITDA $2.5M. Shares fell 6.55% pre-market to $9.99 (market cap ~$268M) reflecting investor concern over the revenue shortfall despite margin and profitability improvements. Management sold subsidiary Bressner for ~$22.4M, expects FY2026 revenue of ~$36.1M (20%-25% growth) with slight losses in H1 and a return to profitability in H2, and highlighted continued investment in PCIe Gen6 products and defense/commercial platform opportunities amid supply‑chain lead‑time risk.

Analysis

OSS’s strategic pivot to ruggedized edge compute has created a business profile that is de-risked from hyperscaler cycles but increasingly exposed to defense procurement timing and program lumpy-ness. That combination amplifies quarter-to-quarter volatility: when supply-chain friction delays components, revenue can slip materially into later quarters even though program economics and margins remain intact, concentrating upside into H2 windows.

The sale of the legacy subsidiary crystallizes optionality — management now has a clean balance sheet and capital to pursue tuck-ins that accelerate systems-level integration (software, thermal solutions, or IP for sensor fusion). A targeted acquisition could be both strategically accretive and quick to scale because defense primes prize single-source, vertically integrated subsystems; conversely, financing deals with equity at current rich multiples would dilute upside and is the principal near-term governance risk.

Market reaction is focused on the headline revenue miss, leaving a gap between sentiment and fundamentals: durable multi-year awards and customer-funded R&D convert into high-margin, annuity-like streams once production ramps. The path to re-rating is predictable — consistent quarterly conversions of backlog into revenue and evidence that supply-chain issues are transitory — but investors must price in asymmetric timing risk (weeks-to-quarters) rather than a binary beat/miss narrative.

Key Decisions for Investors

• Long OSS via defined-cost, multi-quarter call spread (e.g., buy 12–18 month OSS LEAP call, sell a higher-strike call): targeted timeframe 6–12 months to capture H2 backlog conversion and defense award windows. Rationale: limited downside to premium with ~3x+ upside if programs ramp; size 1–2% of portfolio given high idiosyncratic volatility.
• Pair trade — long OSS equity (smaller weight) vs short SMCI (larger weight to match beta): horizon 3–9 months. Thesis: OSS should outperform if defense/commercial edge demand sustains while SMCI re-prices to data-center cyclical weakness; target 15–30% relative outperformance, stop-loss if SMCI outperforms OSS by >20% over 6 weeks.
• Buy short-dated protective puts on OSS (60–120 days) to hedge near-term execution risk around bookings and component lead-time headlines. Keep hedges as inexpensive insurance (1–1.5% of position value) to protect downside while allowing capture of H2 upside.
• Event-driven M&A speculation: accumulate a starter long position ahead of potential strategic M&A activity funded by divestiture proceeds; plan to add on weakness post-confirmation of a non-dilutive—or accretive—transaction. Risk: management may still use equity; cap exposure to <3% until deal terms are visible.